Health Condition 1: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
Conditions
Interventions
None listed
Sponsors
Abbott India Ltd
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or female patients aged >= 18 years 2. Patients newly diagnosed with vitamin D deficiency or insufficiency of known or unknown origin. 3. Patients who are willing to provide written patient authorization 4. Patients with stable anti-hypertension treatment for last 2 months. In case of Hypertension sub-group only. 5. Patients with stable anti-diabetes treatment for last 2 months. In case of Diabetes subgroup only.
Exclusion criteria
Exclusion criteria: 1. Patients already on treatment for vitamin D deficiency/insufficiency 2. Female patients who are pregnant 3. Patients with a serum level of 25(OH)D > 30 ng/mL 4. Patients who are not willing to provide written patient authorization
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To understand the patient profile in terms of demographic and anthropometric measurements, exposure to sunlight, lifestyle pattern, and socioeconomic status 2. To determine the clinical characteristics in terms of clinical signs and symptoms at baseline and weeks 4 and 8Timepoint: Week 4 and 8 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Type and number of comorbidities at baseline. 2. Proportion of patients who are prescribed with vitamin D supplements, including its formulation (as tablets/capsules, injections, or granules in sachets), dose, route, frequency, and duration at weeks 4 and 8 3. Change in 25(OH)D levels from baseline to weeks 4 and 8 4. Number and proportion of patients with adverse events (AEs)/serious AEsTimepoint: Week 4 and 8 | — |
Countries
India
Contacts
Public ContactDr Shivani Acharya
Abbott India Ltd
Outcome results
None listed